Medical Science Liaison

Remote

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Candidates should possess a doctoral-level qualification (PharmD, PhD, MD) with a strong background in radiology or medical imaging. A minimum of 5 years of pharmaceutical or biotech industry experience is preferred, including at least 2 years as a Medical Science Liaison, with prior experience in radiology or imaging-related therapeutic areas being highly desirable.

Responsibilities

The Medical Science Liaison will build and maintain relationships with radiology Key Opinion Leaders and healthcare providers through scientific exchanges, deliver medical education and presentations on products and disease states, and serve as the primary contact for medical and scientific inquiries. They will also support company-sponsored trials, clinical trial site recruitment, and Investigator Initiated Research proposals, assist with medical communications, grant proposals, health economics research, speaker training, Advisory Boards, and sales training, and stay current on disease states and competitive landscapes within the imaging therapeutic area. Additionally, they will attend radiology-focused medical meetings to gather and share scientific and competitive intelligence, requiring up to 60% travel within the US.

Skills

Scientific Exchange

Stakeholder Engagement

KOL Engagement

HCP Engagement

Product Development

Medical Affairs

Pharmaceuticals

Radiology

Azurity Pharmaceuticals

Develops specialized formulations of medicines

About Azurity Pharmaceuticals

Azurity Pharmaceuticals develops specialized formulations of existing medicines to meet the needs of patients who are often overlooked by traditional pharmaceutical companies. Their products include oral suspensions and other forms that are easier to administer, particularly for those who have difficulty swallowing pills or need precise dosing. This focus on creating accessible and effective medications enhances patient compliance and addresses gaps in the pharmaceutical market. Azurity serves healthcare providers, hospitals, and pharmacies, generating revenue through the sale of FDA-approved proprietary medicines across various therapeutic areas, including cardiovascular, central nervous system, and oncology. Their goal is to improve patient outcomes by providing high-quality, innovative medicines tailored to specific medical conditions.

Woburn, MassachusettsHeadquarters

2000Year Founded

$182.2MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Hybrid Work Options

Professional Development Budget

Tuition Reimbursement

Wellness Program

Risks

Product recalls, like Zenzedi's, can damage brand reputation and cause financial losses.

Integration challenges from Slayback Pharma acquisition may disrupt operations.

Reliance on FDA approvals means regulatory delays could impact product launches.

Differentiation

Azurity focuses on innovative dose forms for overlooked patient needs.

Their FDA-approved products ensure safety and efficacy in specialized formulations.

Azurity's acquisition of Slayback Pharma enhances its development and launch capabilities.

Upsides

Growing demand for personalized medicine aligns with Azurity's specialized dose forms.

Increasing chronic diseases boost need for Azurity's innovative drug delivery systems.

FDA's focus on novel formulations benefits Azurity's product pipeline.

Land your dream remote job 3x faster with AI

Try Jobo Free